Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Yi Sun, Lijuan Xu, Hongming Shao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14957-14969
Closed Access | Times Cited: 17

Showing 17 citing articles:

Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 41
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 12
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors
Christopher R. Gardner, Katherine A. Davies, Ying Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2361-2385
Open Access | Times Cited: 21
Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway
Xinqi Zhang, Qianyu Han, Ruilin Hou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5261-5278
Closed Access | Times Cited: 13
Fluorescent probes for detecting and imaging mitochondrial hydrogen sulfide
Yiwen Zhu, Ebenezeri Erasto Ngowi, Ao-Qi Tang, et al.
Chemico-Biological Interactions (2025) Vol. 407, pp. 111328-111328
Closed Access
Development and Evaluation in Rat and Monkey of a Candidate Homochiral Radioligand for PET Studies of Brain Receptor Interacting Protein Kinase 1: [18F](S)-1-(5-(3-Fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one
Susovan Jana, Mudasir Maqbool, Xuefeng Yan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Synthesis and biological evaluation of novel Trifluoromethylated Arylidene-hydrazinyl-thiazoles as neuroprotective agents
Ranjana Aggarwal, Prince Kumar, Suresh Kumar, et al.
Bioorganic Chemistry (2025), pp. 108390-108390
Closed Access
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
Lijuan Xu, Wannian Zhang, Chunlin Zhuang
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 2, pp. 101-124
Closed Access | Times Cited: 10
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
Design, synthesis, and structure–activity relationship studies of 6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole derivatives as necroptosis inhibitors
Zechen Jin, Yang Dai, Yinchun Ji, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2514-2526
Open Access | Times Cited: 1
Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitors
Y.‐C. XIN, Pengcheng Dai, Hongming Shao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 100, pp. 117611-117611
Closed Access | Times Cited: 1
Structure-Based Discovery of a 4,5-Dihydropyrazole-Cored PET Ligand for Imaging of Receptor-Interacting Serine/Threonine-Protein Kinase 1 (RIPK1) in the Brain
Wanqing Li, Xiaojun Zhang, Jingyin Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116803-116803
Closed Access | Times Cited: 1
Profiling of the chemical space on the phenyl group of substituted benzothiazole RIPK3 inhibitors
Yue Xu, Caiquan Liang, Wannian Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106339-106339
Closed Access | Times Cited: 7
Discovery of Sibiriline derivatives as novel receptor-interacting protein kinase 1 inhibitors
Ningjie Cui, Shang Li, Yonglei Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115190-115190
Closed Access | Times Cited: 3
Analysis on benzothiazole necroptosis inhibitors with chiral substitutions in the solvent-accessible region of RIP kinase domain
Hongming Shao, Lijuan Xu, Gechang Li, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106647-106647
Closed Access | Times Cited: 2
Therapeutic implications of necroptosis activation in Alzheimer´s disease
Elizabeth Carrazana, Natalia Salvadores
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access
Page 1

Scroll to top